首页> 美国卫生研究院文献>Cell Death Disease >C9-ALS/FTD-linked proline–arginine dipeptide repeat protein associates with paraspeckle components and increases paraspeckle formation
【2h】

C9-ALS/FTD-linked proline–arginine dipeptide repeat protein associates with paraspeckle components and increases paraspeckle formation

机译:C9-ALS / FTD连接的脯氨酸-精氨酸二肽重复蛋白与副斑点成分结合并增加副斑点形成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A GGGGCC hexanucleotide repeat expansion in the C9ORF72 gene has been identified as the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia. The repeat expansion undergoes unconventional translation to produce five dipeptide repeat proteins (DPRs). Although DPRs are thought to be neurotoxic, the molecular mechanism underlying the DPR-caused neurotoxicity has not been fully elucidated. The current study shows that poly-proline-arginine (poly-PR), the most toxic DPR in vitro, binds to and up-regulates nuclear paraspeckle assembly transcript 1 (NEAT1) that plays an essential role as a scaffold non-coding RNA during the paraspeckle formation. The CRISPR-assisted up-regulation of endogenous NEAT1 causes neurotoxicity. We also show that the poly-PR modulates the function of several paraspeckle-localizing heterogeneous nuclear ribonucleoproteins. Furthermore, dysregulated expression of TAR DNA-binding protein 43 (TDP-43) up-regulates NEAT1 expression and induces neurotoxicity. These results suggest that the increase in the paraspeckle formation may be involved in the poly-PR- and TDP-43-mediated neurotoxicity.
机译:C9ORF72基因中的GGGGCC六核苷酸重复扩增已被确定为肌萎缩性侧索硬化症和额颞痴呆的最常见遗传原因。重复序列扩增经过非常规翻译以产生五个二肽重复序列蛋白(DPR)。尽管DPR被认为具有神经毒性,但尚未完全阐明DPR引起的神经毒性的分子机制。当前的研究表明,聚脯氨酸-精氨酸(poly-PR)是体外毒性最强的DPR,它结合并上调了核散斑组装转录本1(NEAT1),在转录过程中作为支架的非编码RNA起着至关重要的作用。散斑形成。 CRISPR辅助内源性NEAT1的上调会引起神经毒性。我们还表明,poly-PR调节几个副斑点定位异质核核糖核蛋白的功能。此外,TAR DNA结合蛋白43(TDP-43)的表达失调会上调NEAT1的表达并引起神经毒性。这些结果表明,散斑形成的增加可能与poly-PR和TDP-43介导的神经毒性有关。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号